DYN - CIK 0001818794
Dyne Therapeutics, Inc. (DYN) reported net income of -$446.20 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$446.20 | -40.6% |
| FY 2024 | -$317.40 | -34.5% |
| FY 2023 | -$235.90 | -40.3% |
| FY 2022 | -$168.10 | +100.0% |
| FY 2021 | -$149.29M | -151.2% |
| FY 2020 | -$59.44M | -300.0% |
| FY 2019 | -$14.86M | - |
Dyne Therapeutics, Inc. (DYN) reported net income of -$446.20 for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Dyne Therapeutics, Inc.'s net income grew from -$14.86M to -$446.20.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.